Corteva shares rise following JPMorgan upgrade

Corteva, Inc. shares saw a significant increase following an upgrade by JPMorgan Chase & Co., which moved the stock from a neutral rating to overweight. Analyst Jeffrey Zekauskas set a price target of $19.00 per share, suggesting a potential upside of approximately 53% from its previous closing price of $12.39.

The upgrade follows Corteva’s recent structural change, where it completed the spin-off of its seed and genetics business into an independent company named Vylor. As of October 1, Corteva operates exclusively as a crop protection company. JPMorgan analysts noted that the new structure offers an attractive valuation, with the company trading at approximately six times its EBITDA.

Key growth drivers identified include the licensing of new molecules to expand the product portfolio and operational improvements. Other financial institutions have also provided recent outlooks, with Barclays and Mizuho raising price targets, while the consensus among analysts remains a 'Moderate Buy'.